4
Changes in Ownership
Dianthus Therapeutics, Inc. /DE/ Filed Acc 0001562180-19-006220
Chief Medical Officer sold 919 shares at $15.00 ($13,785)
- Chief Medical Officer acquired 919 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| DAVIS JOHN C. JR Chief Medical Officer | 2019-12-20 | Option exercise | +114 | $9.49 | $1,082 | 8,418 | D |
| DAVIS JOHN C. JR Chief Medical Officer | 2019-12-20 | Option exercise | +805 | $9.49 | $7,639 | 9,223 | D |
| DAVIS JOHN C. JR Chief Medical Officer | 2019-12-20 | Sale | −919 | $15.00 | $13,785 | 8,304 | D |
| Derivatives | |||||||
| DAVIS JOHN C. JR Chief Medical Officer | 2019-12-20 | Option exercise · Stock Option (Right to Buy) | −805 | 236,239 | D | ||
| DAVIS JOHN C. JR Chief Medical Officer | 2019-12-20 | Option exercise · Stock Option (Right to Buy) | −114 | 236,125 | D | ||
| Open-market sales · 919 sh · avg $15.00 · $13,785 | |||||||
Loading xslF345X03/primarydocument.xml…